PCN57 TRASTUZUMAB USE FOR METASTATIC BREAST CANCER–IS “MEDIAN TIME TO TREATMENT FAILURE” AN ACCURATE PARAMETER FOR BUDGET IMPACT ANALYSIS?
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63487-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63487-0/fulltext
Title :
PCN57 TRASTUZUMAB USE FOR METASTATIC BREAST CANCER–IS “MEDIAN TIME TO TREATMENT FAILURE” AN ACCURATE PARAMETER FOR BUDGET IMPACT ANALYSIS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63487-0&doi=10.1016/S1098-3015(10)63487-0
First page :
Section Title :
Open access? :
No
Section Order :
339